GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » Gross-Profit-to-Asset %

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Gross-Profit-to-Asset % : 14.27% (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Wanbangde Pharmaceutical Holding Group Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ¥621 Mil. Wanbangde Pharmaceutical Holding Group Co's average Total Assets over the quarter that ended in Mar. 2024 was ¥4,351 Mil. Therefore, Wanbangde Pharmaceutical Holding Group Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 14.27%.


Wanbangde Pharmaceutical Holding Group Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co Gross-Profit-to-Asset % Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.07 25.13 18.91 21.87 14.91

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.43 11.52 13.99 17.31 14.27

Competitive Comparison of Wanbangde Pharmaceutical Holding Group Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Wanbangde Pharmaceutical Holding Group Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wanbangde Pharmaceutical Holding Group Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wanbangde Pharmaceutical Holding Group Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Wanbangde Pharmaceutical Holding Group Co's Gross-Profit-to-Asset % falls into.



Wanbangde Pharmaceutical Holding Group Co Gross-Profit-to-Asset % Calculation

Wanbangde Pharmaceutical Holding Group Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=634.674/( (4218.157+4296.358)/ 2 )
=634.674/4257.2575
=14.91 %

Wanbangde Pharmaceutical Holding Group Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=620.956/( (4296.358+4406.6)/ 2 )
=620.956/4351.479
=14.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Wanbangde Pharmaceutical Holding Group Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Wanbangde Pharmaceutical Holding Group Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Business Description

Traded in Other Exchanges
N/A
Address
Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008
Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.
Executives
Zhao Shou Ming Directors, executives
Wang Tian Fang Director
Li Rong Fang Supervisors
Zhu Jian Xin Directors, executives
Yang Jin Rong Executives
Song Tie He Directors, executives
Song Jian Hua Executives
Pan Yun Chu Director
Yu Ju Ming Executives
Yang Mei Gen Executives
Tao Jian Feng Supervisors
Qian Shu Sheng Executives
Shen Bai Ming Director
Xu Yin Sheng Director
Shuang Zhi Wei Executives

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Headlines

No Headlines